UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 15, 2007 ULTRALIFE BATTERIES, INC. ------------------------- (Exact name of registrant as specified in its charter) Delaware -------- (State or other jurisdiction of incorporation or organization) 0-20852 16-1387013 ------- ---------- (Commission File Number) (I.R.S. Employer Identification No.) 2000 Technology Parkway, Newark, New York 14513 ----------------------------------------------------- (Address of principal executive offices) (Zip Code) (315) 332-7100 -------------- (Registrant's telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: [ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))Item 7.01. Regulation FD Disclosure. Ultralife Batteries, Inc. (the "Company") has received an order valued at more than $800,000 to supply its UBBL12 lithium ion batteries to Cubic Defense Applications, the defense segment of Cubic Corporation. The Company's press release is attached as Exhibit 99.1 to this Form 8-K. The information set forth in this Form 8-K and the attached exhibit is being furnished to and not filed with the Securities and Exchange Commission and shall not be deemed to be incorporated by reference in any filing under the Securities Exchange Act of 1934, as amended, or the Securities Act of 1933, as amended, except to the extent specifically provided in any such filing. Item 9.01. Financial Statements, Pro Forma Financials and Exhibits. (a) Financial Statements of Business Acquired. Not applicable. (b) Pro Forma Financial Information. Not applicable. (c) Exhibits. 99.1 Press Release dated March 15, 2007. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ULTRALIFE BATTERIES, INC. Dated: March 15, 2007 By: /s/ Peter F. Comerford ---------------------------- Peter F. Comerford Vice President of Administration & General Counsel
INDEX TO EXHIBITS (99) Additional Exhibits 99.1 Press Release dated March 15, 2007.
Exhibit 99.1 Ultralife Batteries Receives $800,000 Order to Supply Batteries to Cubic Corporation NEWARK, N.Y.--(BUSINESS WIRE)--March 15, 2007--Ultralife Batteries, Inc. (NASDAQ: ULBI) has received an order valued at more than $800,000 to supply its UBBL12 lithium ion batteries to Cubic Defense Applications, the defense segment of Cubic Corporation. The batteries are used to power Cubic's Weapons Effects Simulation land-based combat training system. Deliveries are expected to begin and be completed in the second quarter. John D. Kavazanjian, Ultralife's president and chief executive officer said, "This order illustrates our leadership role in developing and supplying advanced power sources for use in a wide range of portable defense systems and further demonstrates the growing demand for our products from a diverse set of defense customers." The UBBL12 is a rugged, 15-volt, 7-ampere-hour lithium ion battery containing Ultralife's SmartCircuit(TM) technology and powers the Weapon Effects Simulation system, which features a fully integrated Direct-Fire Weapons Effects Simulation system that includes Cubic's Precision Combat Training System and advanced software-based exercise control and after-action review technology. About Ultralife Batteries, Inc. Ultralife is a global provider of high-energy power solutions and communications accessories for diverse applications. The company develops, manufactures and markets a wide range of non-rechargeable and rechargeable batteries, charging systems and accessories for markets including defense, commercial and consumer portable electronics. Through its portfolio of standard products and engineered solutions, Ultralife is at the forefront of providing the next generation of power systems and accessories. Defense, commercial and retail customers include General Dynamics, Philips Medical Systems, General Motors, Energizer, Kidde Safety, Lowe's, Radio Shack and the national defense agencies of the United States, United Kingdom, Germany, Australia and New Zealand, among others. Ultralife's headquarters, principal manufacturing and research facilities are in Newark, New York, near Rochester. Ultralife's three other operating units are: Ultralife Batteries (UK) Ltd., in Abingdon, England; McDowell Research in Waco, Texas; and ABLE New Energy in Shenzhen, China. Detailed information on Ultralife is available at: www.ultralifebatteries.com. This press release may contain forward-looking statements based on current expectations that involve a number of risks and uncertainties. The potential risks and uncertainties that could cause actual results to differ materially include: Addressing the process of U.S. military procurement, worsening global economic conditions, increased competitive environment and pricing pressures, disruptions related to restructuring actions and delays. Further information on these factors and other factors that could affect Ultralife's financial results is included in Ultralife's Securities and Exchange Commission (SEC) filings, including the latest Annual Report on Form 10-K. Note to editors: A photograph of the UBBL12 battery is available at the following link: www.ultralifebatteries.com/images/lineart/hires/UBBL12_hires.jpg Ultralife(R) and SmartCircuit(TM) are trademarks of Ultralife Batteries, Inc. CONTACT: Ultralife Batteries, Inc. Pete Comerford, 315-332-7100 pcomerford@ulbi.com or Investor Relations: Lippert/Heilshorn & Associates, Inc. Jody Burfening, 212-838-3777 jburfening@lhai.com